Post EBV infection, the body generates specific serum antibodies like P85-Ab, VCA-IgA, Rta-IgG, and Zta-IgA, acting as valuable adjunct markers for early detection and diagnosis of nasopharyngeal carcinoma [19]. This evidence concerns the gene CD79A and nasopharyngeal carcinoma.